Cancer Family
Head and Neck Neoplasm
CI-CAN-00000021Explore in graph →
Non-malignant1,571 active trials17 approved drugs142 evidence items
Loading cancer entity…
Cancer Family
CI-CAN-00000021Explore in graph →
Clinical trials
6,372 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05740774 | Surgical Margin Assessment by 3D Ultrasound | unknown | N/A | 7 | Rigshospitalet, DenmarkOTHER | 1 | Feb 23, 2023 | clinicaltrials |
| NCT05738395 | Symptoms of Frey's Syndrome | unknown | — | 20 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Feb 22, 2023 | clinicaltrials |
| Efficacy and Safety of Immunotherapy Combined With Neoadjuvant Chemotherapy in Patients With Locally Advanced HPV (-) Head and Neck Squamous Cell Carcinoma: a Phase II Clinical Trial |
| unknown |
| Phase 2 |
| 39 |
| Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER |
| 1 |
| Feb 17, 2023 |
| clinicaltrials |
| NCT05727410 | Neoadjuvant Nivolumab, Docetaxel, Cisplatin Therapy Followed by Surgery and Radiation Therapy for Resectable High Grade Salivary Gland Carcinoma | unknown | Phase 2 | 50 | Myung-Ju AhnOTHER | 1 | Feb 14, 2023 | clinicaltrials |
| NCT05728112 | Effectiveness Verification of Using Hydrogen Inhalation to Improve Fatigue, Pain and Quality of Life in Cancer Patients(hydrogen) | unknown | N/A | 30 | Kaohsiung Medical University Chung-Ho Memorial HospitalOTHER | 1 | Feb 14, 2023 | clinicaltrials |
| NCT05724355 | CDK4/6 Inhibitor Plus Camrelizumab for PD-1 Inhibitor Refractory R/M NPC | unknown | Phase 2 | 32 | Sun Yat-sen UniversityOTHER | 1 | Feb 13, 2023 | clinicaltrials |
| NCT04359199 | QUantitative Assessment of Swallowing After Radiation (QUASAR)(QUASAR) | unknown | — | 42 | Loren Mell, MDOTHER | 1 | Feb 10, 2023 | clinicaltrials |
| NCT05721885 | Effect of Nutritional Management on RIOM in Patients With Advanced Head and Neck Cancer | unknown | N/A | 60 | Jing YanOTHER | 0 | Feb 10, 2023 | clinicaltrials |
| NCT05549466 | Targeted or Chemotherapy Combined With Immunotherapy Versus Chemotherapy for PD-1 Inhibitor Refractory R/M NPC | unknown | Phase 2 | 84 | Sun Yat-sen UniversityOTHER | 1 | Feb 8, 2023 | clinicaltrials |
| NCT04405622 | Toripalimab and Gemcitabine in Recurrent or Metastatic Nasopharyngeal Carcinoma. | unknown | Phase 2 | 21 | Sun Yat-sen UniversityOTHER | 1 | Feb 6, 2023 | clinicaltrials |
| NCT05466357 | Application Research on Endoscopic Pseudocapsule-Based Resection for Pituitary Adenomas | unknown | N/A | 30 | Affiliated Hospital of Nantong UniversityOTHER | 1 | Feb 6, 2023 | clinicaltrials |
| NCT05578170 | Efficacy and Safety of Neoadjuvant Pembrolizumab in III-IVA Resectable Oral Squamous Cell Carcinoma(PROBES) | unknown | — | 47 | Nanfang Hospital, Southern Medical UniversityOTHER | 1 | Feb 3, 2023 | clinicaltrials |
| NCT05697926 | Preclinical Research for Personalized TCR-T Therapy for Head and Neck Cancer | unknown | — | 100 | Eye & ENT Hospital of Fudan UniversityOTHER | 1 | Jan 26, 2023 | clinicaltrials |
| NCT05568641 | Vitamin-D Receptor in Laryngeal Squamous Cell Carcinoma | unknown | — | 50 | Sohag UniversityOTHER | 0 | Jan 18, 2023 | clinicaltrials |
| NCT05682703 | A Bidirectional Study in Exploring the Dynamic Changes of Plasma and Urine Metabolites of Nasopharyngeal Carcinoma. | unknown | — | 2,000 | Nanfang Hospital, Southern Medical UniversityOTHER | 1 | Jan 12, 2023 | clinicaltrials |
| NCT05679856 | Vocal Cord vs Whole Laryngeal Radiotherapy for T1aN0 Glottic Cancer(VC-Larynx) | unknown | N/A | 50 | National Cancer Institute, EgyptOTHER | 1 | Jan 11, 2023 | clinicaltrials |
| NCT01946867 | NBTXR3 and Radiation Therapy in Treating Patients With Locally Advanced SCC of the Oral Cavity or Oropharynx | unknown | N/A | 75 | NanobiotixINDUSTRY | 4 | Dec 29, 2022 | clinicaltrials |
| NCT05664906 | Evaluating Chinese Medicine Oral Rinse for Irradiated Oral Mucositis in Head & Neck Cancer Patients | unknown | Phase 1 / Phase 2 | 40 | Chinese University of Hong KongOTHER | 1 | Dec 27, 2022 | clinicaltrials |
| NCT03775525 | Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast Cancer(GEN602) | unknown | Phase 1 | 127 | Genzada Pharmaceuticals USA, Inc.INDUSTRY | 1 | Dec 23, 2022 | clinicaltrials |
| NCT05659186 | PD-1 Inhibitor and Anlotinib Combined With Multimodal Radiotherapy in Recurrent or Metastatic Anaplastic Thyroid Cancer | unknown | Phase 2 | 20 | West China HospitalOTHER | 1 | Dec 21, 2022 | clinicaltrials |
| NCT05654077 | EBV CAR-T Cells for Nasopharyngeal Carcinoma | unknown | Early Phase 1 | 24 | The Affiliated Hospital of Xuzhou Medical UniversityOTHER | 1 | Dec 19, 2022 | clinicaltrials |
| NCT05655663 | Evaluation of Vascular Toxicity of Immune Checkpoint Inhibitors in Patients Head and Neck or Lung Cancer(IMMUNOVASC) | unknown | N/A | 30 | Centre Henri BecquerelOTHER | 1 | Dec 19, 2022 | clinicaltrials |
| NCT05616468 | BGT007 Cell Treatment of Nasopharyngeal Carcinoma | unknown | Early Phase 1 | 23 | The Affiliated Hospital of Xuzhou Medical UniversityOTHER | 1 | Dec 15, 2022 | clinicaltrials |
| NCT05650034 | Post-Operative Radiotherapy De-Escalation of Negative Nodal Regions in Head and Neck Squamous Cell Carcinoma | unknown | N/A | 57 | National Cancer Institute, EgyptOTHER | 1 | Dec 14, 2022 | clinicaltrials |
| NCT04650919 | Aortic Laryngeal Rehabilitation Graft(GRAAL) | unknown | N/A | 4 | University Hospital, Strasbourg, FranceOTHER | 1 | Dec 13, 2022 | clinicaltrials |
| NCT05588973 | Prevention of Radiodermatitis in Breast and Head and Neck Cancer Patients in Cyprus(MEDISKIN) | unknown | N/A | 100 | Angelos KassianosOTHER | 1 | Dec 6, 2022 | clinicaltrials |
| NCT05634655 | Dissecting the Mechanism of DNA Methylation on the Invasiveness of Pituitary Tumors. | unknown | — | 500 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Dec 2, 2022 | clinicaltrials |
| NCT05627310 | Development and Validation of a Deep Learning System for Nasopharyngeal Carcinoma Using Endoscopic Images | unknown | — | 50,000 | Eye & ENT Hospital of Fudan UniversityOTHER | 1 | Nov 25, 2022 | clinicaltrials |
| NCT01855451 | Weekly Cetuximab/RT Versus Weekly Cisplatin/RT in HPV-Associated Oropharyngeal Squamous Cell Carcinoma(HPVOropharynx) | unknown | Phase 3 | 189 | Trans Tasman Radiation Oncology GroupOTHER | 2 | Nov 18, 2022 | clinicaltrials |
| NCT05415098 | Study of Safety, Pharmacokinetic and Efficacy of APG-5918 in Advanced Solid Tumors or Lymphomas | unknown | Phase 1 | 90 | Ascentage Pharma Group Inc.INDUSTRY | 1 | Nov 16, 2022 | clinicaltrials |
| NCT05532384 | Effect of Early Postoperative Drinking Water on Postoperative Recovery Quality of Patients With Thyroid Surgery | unknown | N/A | 94 | Peking Union Medical College HospitalOTHER | 1 | Nov 15, 2022 | clinicaltrials |
| NCT04374448 | Utility of Indocyanine Green Fluorescence in Endoscopic Sinonasal and Skull Base Surgery(NIRFICG) | unknown | N/A | 40 | St. Paul's Sinus CentreOTHER | 0 | Nov 14, 2022 | clinicaltrials |
| NCT05614375 | Endoscopic Surgery in the Treatment of Soft Tissue Sarcoma in Nasal and Paranasal Sinus | unknown | — | 40 | Eye & ENT Hospital of Fudan UniversityOTHER | 1 | Nov 14, 2022 | clinicaltrials |
| NCT05143268 | Acupuncture for Dysphagia in Head and Neck Squamous Cell Carcinoma(ACP-HN) | unknown | — | 90 | Lorenzo LiviOTHER | 1 | Nov 10, 2022 | clinicaltrials |
| NCT05611463 | Camrelizumab Plus Docetaxel and Cisplatin in Recurrent or Metastatic Oral Squamous Cell Carcinoma Patients(CHANCE) | unknown | Phase 2 | 25 | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong UniversityOTHER | 1 | Nov 10, 2022 | clinicaltrials |
| NCT03837808 | Radiotherapy Plus Concurrent Nimotuzumab or Cisplatin in Stage II-III Nasopharyngeal Carcinoma | unknown | Phase 3 | 384 | Sun Yat-sen UniversityOTHER | 1 | Nov 7, 2022 | clinicaltrials |
| NCT05607225 | Deep Learning-based Classification and Prediction of Radiation Dermatitis in Head and Neck Patients | unknown | — | 300 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Nov 7, 2022 | clinicaltrials |
| NCT05602792 | A Study of T3011 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumors | unknown | Phase 1 / Phase 2 | 233 | ImmVira Pharma Co. LtdINDUSTRY | 1 | Nov 2, 2022 | clinicaltrials |
| NCT05601401 | Phase II Study of RC48-ADC in Treating Patients With Salivary Gland Tumors Expressing HER2 | unknown | Phase 2 | 10 | Peking Union Medical College HospitalOTHER | 1 | Nov 1, 2022 | clinicaltrials |
| NCT05003427 | 68Ga-FAPI-04 PET/CT for the Detection of Oral Carcinoma | unknown | Early Phase 1 | 30 | Peking Union Medical College HospitalOTHER | 1 | Oct 28, 2022 | clinicaltrials |
| NCT03432299 | Radiofrequency Ablation of Low Risk Papillary Thyroid Microcarcinoma(RFAforPTMC) | unknown | N/A | 100 | Seoul National University HospitalOTHER | 1 | Oct 26, 2022 | clinicaltrials |
| NCT03817307 | Validation of USPIO-enhanced MRI for Detection of Lymph Node Metastases in Head and Neck Carcinoma(USPIO-NECK) | unknown | N/A | 25 | Radboud University Medical CenterOTHER | 1 | Oct 26, 2022 | clinicaltrials |
| NCT04803331 | SPIO-enhanced MRI in Oral Cancer for Sentinel Lymph Node Identification(MAG-NODE) | unknown | N/A | 10 | Radboud University Medical CenterOTHER | 1 | Oct 26, 2022 | clinicaltrials |
| NCT05595265 | Expression of Programmed Death Ligand-1 (PD-L1) in Nasopharyngeal and Hyypopharyngeal Carcinoma | unknown | — | 50 | Sohag UniversityOTHER | 1 | Oct 26, 2022 | clinicaltrials |
| NCT05468554 | Evaluation of Metformin Effect on the Fertility of Women Treated With 131I for Thyroid Cancer(METHYR) | unknown | Phase 3 | 160 | Medical University of BialystokOTHER | 1 | Oct 19, 2022 | clinicaltrials |
| NCT02063399 | Prospective Nasopharyngeal Carcinoma Screening Using Plasma Epstein-Barr Virus DNA Analysis | unknown | — | 20,302 | Chinese University of Hong KongOTHER | 1 | Oct 17, 2022 | clinicaltrials |
| NCT05027204 | A Study of Docetaxel for Injection (Albumin-bound) in Combination With Nivolumab in Patients With Head and Neck (SCCHN) | unknown | Phase 1 / Phase 2 | 94 | CSPC ZhongQi Pharmaceutical Technology Co., Ltd.INDUSTRY | 1 | Oct 13, 2022 | clinicaltrials |
| NCT05567341 | Remote Ischemic Preconditioning in Vestibular Schwannoma Surgery(RIC-VS) | unknown | N/A | 120 | University Hospital TuebingenOTHER | 1 | Oct 5, 2022 | clinicaltrials |
| NCT05556499 | The Bone-parathyroid Crosstalk in Primary Hyperparathyroidism(PARABONE) | unknown | — | 100 | I.R.C.C.S Ospedale Galeazzi-Sant'AmbrogioOTHER | 1 | Sep 30, 2022 | clinicaltrials |
| NCT00997906 | Cisplatin and RT With or Without Gemcitabine, Carboplatin, and Paclitaxel in Treating Patients With Locally Advanced NPC | unknown | Phase 2 / Phase 3 | 172 | National Cancer Centre, SingaporeOTHER | 1 | Sep 29, 2022 | clinicaltrials |
Data updated 23 days agoSource updated Feb 23, 2023source: clinicaltrials